Ligand Pharma (LGND) PT Lowered to $130 at Benchmark

February 22, 2022 6:42 AM EST Send to a Friend

Benchmark analyst Robert Wasserman lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ligand Pharma (LGND) PT Lowered to $130 at Benchmark

Member Login

Free News Feed